A novel antibacterial gene transfer treatment for multidrug-resistant Acinetobacter baumannii-induced burn sepsis

Journal of Burn Care and Research

Volumn 28, Issue 1, 2007, Pages 6-12

  Shankar, Ravi ^a   He, Li Ke ^a   Szilagyi, Andrea ^a   Muthu, Kuzhali ^a   Gamelli, Richard L ^a   Filutowicz, Marcin ^c   Wendt, Jennifer L ^b   Suzuki, Hideki ^b   Dominguez, Miguel ^b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b ConjuGon Inc ^*  (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; COLICIN E3; PLASMID VECTOR; TRA PROTEIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM ISOLATE; BURN INFECTION; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE MODEL; ERADICATION THERAPY; GENE DELIVERY SYSTEM; GENE THERAPY; GENE TRANSFER; IN VITRO STUDY; MALE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; SURVIVAL RATE; WOUND INFECTION;

ACINETOBACTER BAUMANNII; ANIMALS; BURNS; CONJUGATION, GENETIC; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; GENE THERAPY; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; PLASMIDS; SEPSIS; TRANSDUCTION, GENETIC; TRANSFECTION;

EID: 33846167443     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e31802c8861     Document Type: Article

References (27)

1. Sargent RL. Management of blisters in the partial thickness burn: an integrative research review. J Burn Care Res 2006;1:66-81.
2. Wallace BH, Caldwell FT, Jr, Cone JB. The interrelationships between wound management, thermal stress, energy metabolism, and temperature profiles of patients with burns. J Burn Care Rehabil 1994;15:499-508.
3. Woodson LC, Sherwood ER, Morvant EM, Peterson LA. Anesthesia for burn patients. 2nd ed. London: W.B. Saunders; 2002.
4. Krizek TJ, Davis JH. Experimental Pseudomonas burn sepsis - evaluation of topical therapy. J Trauma 1967;7:433-42.
5. Krizek TJ, Davis JH, Desprez JD, et al. Topical therapy of burns: experimental evaluation. Plast Reconstr Surg 1967;39:248-55.
6. Smith JW, Gamelli RL, Jones SB, et al. Immunologic responses to critical injury. J Intensive Care Med 2006;21:160-172.
7. Krizek TJ, Robson MC, Kho E. Bacterial growth and graft survival. Surg Forum 1967;18:518-9.
8. Van Looveren M, Goossens H. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect 2004;10:684-704.
9. Levin AS, Barone AA, Penco J, et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 1999;28:1008-11.
10. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999;284:1318-22.
11. Anderl JN, Franklin MJ, Stewart PS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2000;44:1818-24.
12. Leid JG, Shirtliff ME, Costerton JW, et al. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun 2002;70:6339-45.
13. Hornef MW, Wick MJ, Rhen M, et al. Bacterial strategies for overcoming host innate and adaptive immune responses. Nat Immunol 2002;3:1033-40.
14. Scott PT, Fishbain J, Craft DW, et al. Acinetobactr baumannii infections amongpatients at military facilities treating injured U.S. Service Memnbers, 2002-2204. MMWR, CDC Report 2004;53:1063-6.
15. Walker HL, Mason AD, Jr. A standard animal burn. J Trauma 1968;8:1049-51.
16. Simon R, Priefer UB, Puhler A. A broad host range mobilization system for in vivo genetic engineering: transposan mutagenesis in Gram negative bacteria. Bio Technol 1985;1:784.
17. Bowman CM, Dahlberg JE, Ikemura T, Konisky J, Nomura M. Specific inactivation of 16S ribosomal RNA induced by colicin E3 in vivo. Proc Natl Acad Sci USA 1971;68:964-8.
18. Markou N, Apostolakos H, Koumoudiou C, et al. Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care 2003;7:R78-83.
19. Takahashi H, Tsuda Y, Takeuchi D, Kobayashi M, Herndon DN, Suzuki F. Influence of systemic inflammatory response syndrome on host resistance against bacterial infections. Crit Care Med 2004;32:1879-85.
20. Nystrom PO. The systemic inflammatory response syndrome: definitions and aetiology. J Antimicrob Chemother 1998;41 (Suppl A):1-7.
21. Pristovsek P, Kidric J. The search for molecular determinants of LPS inhibition by proteins and peptides. Curr Top Med Chem 2004;4:1185-201.
22. Diks SH, Richel DJ, Peppelenbosch MP. LPS signal transduction: the picture is becoming more complex. Curr Top Med Chem 2004;4:1115-26.
23. Desnottes JF. Review of meeting: Antibiotic discovery: exploiting new understanding of mechanism of action. Clin Microbiol Infect 1996;1:281-5.
24. Desnottes JF. New targets and strategies for the development of antibacterial agents. Trends Biotechnol 1996;14:134-40.
25. Schauder S, Bassler BL. The languages of bacteria. Genes Dev 2001;15:1468-80.
26. Taga ME, Bassler BL. Chemical communication among bacteria. Proc Natl Acad Sci USA 2003;100 (Suppl 2):14549-54.
27. Whiteley M, Lee KM, Greenberg EP. Identification of genes controlled by quorum sensing in Pseudomonas aeruginosa. Proc Natl Acad Sci USA 1999;96:13904-9.